Fortegra

Fortrea is a leading global contract research organization (CRO) that provides comprehensive clinical development and patient access solutions to the pharmaceutical, biotechnology, and medical device industries. Formed in 2023 through the spin-off of Labcorp's Clinical Development and Commercialization Services business, the company operates in over 90 countries and supports all phases of clinical trials (Phase I-IV). Fortrea offers a wide range of services including clinical pharmacology, trial management, and technology-enabled solutions to accelerate the delivery of life-changing therapies. The company serves a diverse client base, ranging from emerging biotechs to large multinational pharmaceutical corporations.